New Parathyroid Hormone Disease Guidelines Introduced at ASBMR Meeting

According to a recent article from MedPage Today, new clinical guidelines involving parathyroidism were previewed at the American Society for Bone and Mineral Research (ASBMR) meeting last month. Hypoparathyroidism Hypoparathyroidism…

Continue Reading New Parathyroid Hormone Disease Guidelines Introduced at ASBMR Meeting
First in-Depth Study Investigates Chronic Hypoparathyroidism in Pregnancy
source: pixabay.com

First in-Depth Study Investigates Chronic Hypoparathyroidism in Pregnancy

A recent study investigated the experiences of patients with chronic hypoparathyroidism in pregnancy. The study ultimately found that these patients typically had low risk pregnancies and normal outcomes. However, they…

Continue Reading First in-Depth Study Investigates Chronic Hypoparathyroidism in Pregnancy
Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021
rawpixel / Pixabay

Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021

  At the Endocrine Society's Annual Meeting, or ENDO 2021, Amolyt Pharma ("Amolyt") shared positive clinical data from a Phase 1 clinical trial evaluating AZP-3601 for patients with hypoparathyroidism. Although…

Continue Reading Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021
First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601
DarkoStojanovic / Pixabay

First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601

Amolyt Pharma has recently announced that they have dosed the first patient in their trial of AZP-3601, a treatment for hypoparathyroidism. According to GlobeNewswire, this treatment will adequately address the…

Continue Reading First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601
International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy
Source: Pixabay

International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy

Hypoparathyroidism Hypoparathyroidism (HP) is caused by low levels of the parathyroid hormone (PTH). Most people develop this disease after thyroid surgery as a result of accidental damage/removal of the parathyroid…

Continue Reading International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy